Status
Clinical and regulatory status
What OXALIA is today, what it is for, and what it does not do. Three questions a healthcare institution needs to settle before any others.
Current status
- Decision-support software intended for healthcare professionals.
- Under development and clinical validation, together with our institutional partners.
- Neither CE marking nor FDA clearance to date: OXALIA is not marketed as a certified medical device.
Intended use
- Intended users: radiologists and clinicians practising within a healthcare institution.
- Exams analysed: frontal chest radiographs in standard DICOM format.
- Anomalies covered: twenty classes across eight physiopathological families.
Limitations
- OXALIA does not replace medical interpretation and establishes no diagnosis.
- The final decision rests with the healthcare professional, who remains solely responsible for it.
- An absence of detection is not an absence of pathology.
- The output is a reading aid: it replaces neither the clinical examination nor further investigations.
The detection module covers 20 classes across 8 physiopathological families. See the full list
A question about the scope of use?
See OXALIA in a setting close to your own radiology workflow.